kristijan

Mikey1970, you now realize George Kerry is below par at best! Please feel free to use this great site for research and find among many great surgeons around the world the right one for fix a poor hair transplant done by George Kerry. I wish you all the best

Mikey1970, George Kerry is poor at best. I would like to show you in person what he has done on my head and you and anyone else would run miles away from this guy. He has never told me about possible future hair loss and my procedure was done when I was 24 years old. Anyone out there just avoid George Kerry from Adelaide. If he was that good as you had claimed in you previous posts he would have had a few past patients from Australia posting some reviews about him but there are none. I have been member of this great forum for years. I do not comment on this hair restoration network very often but I use it and do my own research on this site on weekly basis.

Hi mate, I would NOT consider anything in Adelaide or Australia as through my research over the years I have not found anyone with consistently good results. Another and very important thing to consider is that Australian surgeons are the most expensive in the world and I think it is very far from being the value for money in terms of quality and the money invested. I would suggest to you to do a good research regarding potential hair transplant on this site as it got all you need to make decision on your hair transplant surgeon. Good luck!! Regards Kris

Hi Sebastion, I am also from Australia and have been a member of this site for years and finally decided about undertaking my procedure with Dr. Doganay next year but after some members have posted a few unsatisfactory outcomes I have now changed my mind and won't be going with him. I have been the member and observer on this forum for years and i have reached following conclusion: as this site starts promoting some surgeons and they get approved by members and as a result they start getting increasing number of patients and in order to serve increase in demand they start employing new inexperienced and unskilled staff to meet demand and earn more revenue the quality of work drops and therefore we have increased number of unhappy patients. Any hair transplant that goes wrong can lead to permanents psychological and financial pains that those unhappy people have to live with for years to come. I have had one of those poor outcome more than a decade ago and I still carry psychological pain from that procedure. When I thought that I had finally found right surgeon for my procedure to fix my years long problem and to regain confidence in myself I now have to look for another surgeon. If you weigh up quick money against reputation in the long run I know which way I will be going. All potential hair transplant patients are much better educated compared to years ago as internet has created a global forum where we share experiences and exchange information about the quality of hair transplant surgeons worldwide. I just hope that greed (money making) has not risen above quality of work as we past and potential patients deserve much more and those surgeons not performing satisfactory results should be dealt with. Lets ongoing and positive reputations lead to recommendation rather than past short glories. We deserve much better in this time and age. As very keen reader of number of posts here lately a quite a few members have expressed concerns with clinics doing multiple surgeries a day (greed for revenue) we can only come to one conclusion and that conclusion is ever increasing number of unhappy people. I my opinion only one person a day should be a way to go! I got burned badly in the past and won't be making any uninformed decision ever again and want to win this battle and BE MY OLD MYSELF!

Hi HARIRI, In the past you used to praise work of Hakan Doganay as being the best FUE surgeon in Turkey but now in your recent discussions with other forum members on this site you are claiming to potential patients that they won't find better FUE surgeon than Dr. Koray Erdogan in Turkey. Could you please elaborate a bit more why you have formed such opinion as Dr. Koray Erdogan being better that Dr. Hakan Doganay? I am considering having FUE in Turkey in 1-2 years so I need to pick one of them so could you please let me know about pros and cons of above FUE hair transplant surgeons?

Hi Modenese, Happy growing mate

June 2012 Premier hair transplant surgeon Herbert S. Feinberg, MD, today announced the implementation of the ARTAS® System of Restoration Robotics, Inc. in his Englewood-based practice. As the first and only FDA cleared, physician controlled, computer-assisted technology for harvesting follicular units directly from the scalp, the ARTAS System provides new and exciting possibilities for both physicians and patients. By utilizing sophisticated digital mapping and precision robotics, the system delivers beautiful, natural-looking results with minimal invasiveness. "In any medical field, it's important to stay on top of industry developments and take advantage of new technologies," commented Dr. Feinberg. "The ARTAS System allows me to do just that for the hair transplant industry. By utilizing it within my practice, I can provide my patients improved results in a safe, effective and comfortable manner." "We're thrilled to see Dr. Feinberg bring the ARTAS System into his practice," said Jim McCollum, President & CEO of Restoration Robotics. "Our mission is to truly revolutionize the way contemporary hair transplantation is performed. When globally respected surgeons such as Dr. Feinberg adopt our technology, that mission is realized." Hair Loss by the Numbers According to the International Society of Hair Restoration Surgery (ISHRS), at least 35 million men in the United States are affected by male pattern baldness or androgenetic alopecia. By age 50, approximately 50% of men will experience some degree of appreciable hair loss. Hair transplantation moves healthy, functioning follicles to the areas of the patient's scalp most impacted by baldness for more dramatic results. New hair continues to grow over the course of a full year, resulting in a gradual change in the patient's appearance over time. Hair transplantation is the only permanent solution for hair loss. About Dr. Herbert Feinberg Dr. Feinberg, the founder of the Dermatology and Hair Transplant Center in Englewood, NJ, has been performing hair transplants for over thirty years. He is a board-certified Diplomate of the American Board of Dermatology and Fellow of the American Academy of Dermatology. His current memberships include the International Society of Hair Restoration Surgery, the American Society for Dermatologic Surgery, the International Society of Cosmetic Surgery, American Academy of Cosmetic Surgery and the American Society for Laser Medicine and Sugery. Previously, he served as president of the North Jersey Dermatological Society and Chairman of The Cosmetics and Skin Care Committee of the Bergen County Medical Society. Dr. Feinberg authored the frequently quoted book All About Hair, and has been interviewed extensively on radio and television. About Restoration Robotics Restoration Robotics, Inc., a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing its state-of- the-art image-guided ARTAS® System. This interactive, computer assisted system uses image guided technology to enhance the quality of hair follicle harvesting for the benefit of physicians and their patients. To learn more about the ARTAS® System and its unique technology . To learn more about hair loss and restoration, please visit the International Society of Hair Restoration Surgeons

June 2012 Finding a way to restore hair growth after substantial hair loss is something of an obsession worldwide. Investigators at the Society of Nuclear Medicine's 2012 Annual Meeting presented how stem cell research for the development of new hair follicles can be monitored with an optical imaging technique that uses bioluminescence, the same process that allows fireflies to light up. There is a host of treatments available for hair loss, including creams and drugs, but these have not shown to be very effective for hair growth. Hair stem cells signal the actual regeneration of hair follicles and natural hair. A molecular imaging technique called bioluminescence is used to display processes at the cellular level. Bioluminescent signal is generated in specific chemical substances called substrates. These signals are easily recognized with very sensitive optical imaging systems that can see what is happening in the smallest places—in this case in hair stem cells. "Hair regeneration using hair stem cells is a promising therapeutic option emerging for hair loss, and molecular imaging can speed up the development of this therapy," saysByeong-Cheol Ahn, M.D., Ph.D., professor and director of the department of nuclear medicine at Kyungpook National University School of Medicine and Hospital in Daegu, South Korea. "This study is the first study of hair follicle regeneration using an in vivo molecular imaging technique." The current research involves grafting hair stem cells in animal models to investigate if they can grow and proliferate as normal cells do. The progress of hair stem cell therapy is non-invasivelytracked with bioluminescentreporter genes in specialized substrates. There are several bioluminescent reporter genes originating fromnot only fireflies, but also beetles, glowworms and other bioluminescent organisms. The strategy of using bioluminescent reporter genesis ideal for stem cell research, because bioluminescence works only in living cells. In this study, researchers used bioluminescence imaging usingfirefly luciferase coupled with D-luciferin to monitor the engraftment of hair follicle stem cells—called newborn fibroblasts—in mice to track their viability and development into hair folliclesover time. Bioluminescence imaging was performed five times over the course of 21 days after transplantation of the stem cells. Results of the study showed successful bioluminescence imaging forhair regeneration with hair stem cell transplantation, and new hair follicles were apparent on the surface of skin samples under microscope. More studies will have to be conducted before clinical trials could be initiated to verify whether this therapy would work for human hair regeneration.

Two men walk into a pharmacy, one is bald and the other is not. They're caught on surveillance cameras boosting some merchandise — and it seems the goods they lifted are a matter of manly pride. Cops are searching for what we're dubbing the Long Island Rogaine Thieves. NBC New York says the twosome entered a CVS on Long Island on Dec. 17. They scooped up three boxes of Rogaine, a hair loss product for men (we know you've seen the commercials) and placed them into a gift bag. Then they simply sauntered out with their loot, without stopping to pay at the register. That move is called "shoplifting." While police are definitely stressing the bald man thing in their search for the thieves and showing his picture in news bulletins, it's probably more likely the non-bald man will get some benefit out of the Rogaine. You see, we read up a bit on Rogaine, and it doesn't appear that the topical treatment offers to "cure" baldness, just stimulate hair growth and slow the balding process. So for our bald pal, that whole shoplifting thing might've been a waste. Cops say the pilfered Rogaine is worth about $150, and are offering a reward of up to $5,000 for information leading to an arrest.

Nov 2011 Although narrowband ultraviolet B (NB UVB) phototherapy is a well-established treatment in many dermatosis, there is little evidence of efficacy of this method for alopecia areata (AA) treatment in the literature. We undertook a retrospective review of the 25 AA patients treated with NB UVB. Intramuscular triamcinolone acetonide injections per month were used as concomitant treatment in some patients who did not have any contraindication. Eight patients (32%) received monthly intramuscular corticosteroid injections. Four (22.2%) and two (20%) patients achieved excellent response in extensive patchy hair loss patients and entire scalp hair loss patients, respectively. Four of six patients who achieved excellent response also received monthly intramuscular corticosteroid injections. When patients receiving systemic corticosteroid injections were compared with patients given only NB UVB with respect to the treatment responses, a statistically significant difference was seen in patients who achieved excellent response. NB UVB is not an effective treatment with only 20% excellent treatment responses in patients with severe AA, most of whom were also treated with systemic corticosteroids.

Nov 2011 A local hair transplant doctor is starting a novel research study to bring to the field of hair transplantation a method of addressing surgical scars that is already used in other reconstructive and aesthetic surgeries. Dr. Marco Barusco, a hair transplant surgeon with over 12 years of experience, wants to determine if BellaDerm® - a natural dermal graft - will improve the appearance of the scalp of hair transplant patients. BellaDerm® is donated human skin that is processed to remove both epidermal and dermal cells. What remains is a tissue matrix capable of natural and full regeneration of cells and blood vessels after it is implanted. This research is being supported by the Musculoskeletal Transplant Foundation (MTF), the largest not-for-profit tissue bank in the U.S. and manufacturer of BellaDerm. The project was reviewed and approved by an independent Institutional Review Board (IRB) that is not associated with Tempus Hair Restoration or MTF. At this time, Dr. Barusco is the only doctor conducting this type of research. BellaDerm will be used to fill in and possibly reduce scarring that may occur in the area from where the hair is removed for the transplant. Dr. Barusco is currently looking for 30 patients to participate in this study; fifteen patients who have already had one or more hair transplants and 15 patients who have never had a hair transplant procedure. Patients must be between the ages of 20 and 60 years old, have Male or Female Pattern Hair Loss, have no major medical problems and can be available for follow-up visits at the Tempus Hair office located at 5537 S. Williamson Blvd., Suite 752 in Port Orange, Florida. Patients will be asked to return for follow-up visits seven times throughout a period of nine months, and will receive compensation for their travels. Those interested in participating should contact Tempus Hair Restoration and Dr. Marco Barusco to schedule a free consultation and learn more about the study. About Tempus Hair Restoration: Tempus Hair Restoration was founded by Board Certified hair transplant surgeon Dr. Marco Barusco and offers hair restoration solutions from medications and laser therapy to surgical procedures. Our main priority is to provide clients with education about their hair loss and the best course of action to achieve their goals.

Nov 2011 Biostem US Corporation a regenerative medicine company, announced completion of a two year study on treating Alopecia Areata, thought to be an autoimmune disease, which causes sudden hair loss. On October 28th, John Satino, President of Biostem, announced results of a two year consumer study conducted at a Biostem affiliate clinic in Florida at The international Stem Cell & Cicatrical Alopecia Symposium. The Symposium was held in Bethesda, Maryland and sponsored by Case Western Reserve School of Medicine and The National Institutes of Health Rare Disease Research Office. The study involved 700 patients, with results showing renewed hair growth in 80% of the participants. The treatment, developed by Biostem, includes a combination of the patients own blood, utilization of growth factors, laser treatments for bio-photo stimulation, and a nutraceutical designed to stimulate hair follicle growth. This unique combination of treatments is known as "The Biostem Method." "We are very encouraged by these positive results and our ability to help the large number of men and women experiencing hair loss, said Satino. Biostem will continue to improve the process, and expand its availability to licensed medical practitioners through a license and affiliate program to be available in the next few months." A central focus of the Biostem Method uses the patients' own blood which is processed to become Platelet Rich Plasma (PRP), a concentration of the body's own cells which contain healing and growth factors. PRP has come to recent national attention when used to treat soft tissue repair in notable athletes such as Tiger Woods and Terrell Owens. While the Biostem Method must be performed in an office setting, Satino noted that the nutraceutical supplements, which are an essential part of the process, can be obtained separately by contacting the company.

Nov 2011 The drug, which in its earliest, unsexiest incarnation existed solely as a glaucoma treatment, is best known as the U.S. Food and Drug Administration-approved wonder drug that can grow and darken your poor listless lashes . Now, it's being tested for a new use: growing hair on your dome. No one tracks just how many doctors across the country are using Latisse off-label to target hair loss, but Dr. Alan Bauman, a Boca Raton, Fla., board-certified hair restoration physician has been using the drug this way for about three years, beginning around the time the FDA approved it for eyelash growth in December 2008. He describes his own personal "eureka!" moment: "Patients who were using it for eyelashes sometimes have eyebrow problems, so it’s a short hop to the eyebrows," he explains. "So, of course, if it was working there, too — from the eyebrows, it’s just a short hop to the hairline." Allergen, the health care company that manufactures the eyelash enhancer, is currently testing the safety and efficacy of a new formulation of bimatoprost, the active pharmaceutical ingredient in Latisse, in growing hair on the scalp, says Heather Katt, a spokeswoman for Allergen. The appeal of using Latisse for hair loss is its ease and convenience, as it seems to only require one drop to the affected area once a day; minoxidil (better known as Rogaine) requires two, and Propecia requires daily pill taking. Bauman says he sees about 1,000 new hair loss patients each year, about 700 of which end up on some kind of medical management — and so far, he's only used Latisse on a "couple dozen" patients, usually those who are allergic to the usual treatments, which is what happened to 70-year-old Rhoda Kelly. Kelly's hair was thinning a bit on the back of her head, so she tried Rogaine, but suffered a bad allergic reaction. So Bauman suggested she try Latisse. Kelly started to see noticeable results about four months after starting Latisse, as her thin hair started to grow in thicker. Now, 14 months later, Kelly says, "My hair is in much better condition — it looks healthy." She's still using Latisse, combined with "a slew of other vitamins," including a pharmaceutical-grade biotin and a marine-derived protein-polysaccaride, and a protective sun hat. Kelly, by the way, has strawberry blonde hair, which has gotten lighter after years in the Florida sun. It hasn't darkened after using Latisse. When Latisse first hit the market, much ado was made about one of the more surprising risks: In rare cases, it could cause light eyes to turn brown. Bauman says he hasn't seen any evidence that this applies to hair, or the skin on the scalp, for that matter. On the left is a photo of Rhoda Kelly's hair before using Latisse, which had started to thin a bit. On the right, Kelly's hair is thicker after using Latisse daily. The major drawback: It's expensive. Each 2-ounce bottle costs $100 to $150 — and some patients will run through two or three bottles a month, Bauman says. "Expense is a big disadvantage, but perhaps the biggest problem with this technology is that it does not restart hair growth for hair that has stopped growing," points out Perry Romanowski, a cosmetic chemist and one of the brains behind the popular beauty blog, The Beauty Brains. "If it works on scalp hair at all (and this hasn't been definitively proven), it will only be able to thicken existing, working hair follicles." Basically: If you already have a bald patch, Latisse can't help you there. "Since what people really want from this product is something that will bring their hair back, I suspect that they will be disappointed because that will not happen," Romanowski says. "Are a few thicker, fuller strands going to be worth the expense? Perhaps to some people.

Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia November 2011 Before now, there has been no study of finasteride use exceeding 1 year in Japanese men with androgenetic alopecia (AGA) except the study subsequently conducted from the development phase. Since the launch of finasteride, no study in a larger population had been reported. Ethnic variation of the onset age, progressive nature and degree of hair loss of androgenetic alopecia are known. The therapeutic effect of oral finasteride (Propecia) was examined on androgenetic alopecia of Japanese men. The efficacy and safety of finasteride (1 mg tablet) was evaluated in Japanese men with AGA in the long term. The study enrolled 3177 men given finasteride 1 mg/day from January 2006 to June 2009 at our clinic. Efficacy was evaluated in 2561 men by the modified global photographic assessment; the photographs were assessed using the standardized 7-point rating scale. Safety data were assessed by interviews and laboratory tests in all men enrolled in the study. The overall effect of hair growth was seen in 2230 of 2561 men (87.1%), in whom hair greatly (11.1%), moderately (36.5%) and slightly (39.5%) increased. The response rate improved with increasing duration of treatment. Adverse reactions occurred in 0.7% (23/3177) of men; seven men discontinued treatment based on risk-benefit considerations. No specific safety problems associated with long-term use were observed. This study represents data collected at a single institution. Many patients did not receive follow-up examination. In Japanese men with AGA, oral finasteride used in the long-term study maintained progressive hair regrowth without recognized side-effect.

"The new product, called Hair Stemulating Complex for Women, was developed using BRS' stem cell released molecules technology called S2RM Technology". BioRegenerative Sciences, Inc., a privately owned stem cell therapeutics corporation headquartered in San Diego, CA, USA, announced today the release of BRS’s human hair regrowth product for women, called Hair Stemulating Complex for Women. Clinical trials in men and women have shown significant hair growth within 4-6 weeks following the daily application of the stem cell-based formulation. Dr. Greg Maguire, CEO of BioRegenerative Sciences, said “HSC is formulated using BRS’s core technology where the molecules from multiple stem cell types are used to mimic the natural healing and growth processes of the human body. Our S2RM TechnologyTM nourishes the scalp’s stem cell niche where the hair and the hair’s pigmentation develop.” Dr. Rita Friedman, a member of BRS’ Scientific Advisory Board, added “For the millions of men and women who struggle with their hair loss, the results of our HSC trial indicate the potential for a highly effective treatment option that stimulates growth of new hairs along with increasing the thickness of existing hairs, doing so with increased natural pigmentation of the hair. BRS’ new product called HSC represents a non-invasive and effective shift from conventional treatment options to one that can promote the growth of new or dormant hairs using the body's own naturally occurring regenerative mechanisms.” Of the over 87 million people in the United States who suffer from hair loss, estimates suggest that only 2-7% seek surgical or pharmacological treatment. These data are true world-wide because of the lack of effective medical options for this widespread condition. Hair Stemulating Complex from BioRegenerative Sciences is a new, non-invasive, and effective means for treating hair loss. Launch of Hair Stemulating Complex for Men is expected 3rd quarter 2011. (Link removed by moderator. Violated Terms of Service)